Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2.368
Zitationen
18
Autoren
2015
Jahr
Abstract
INTRODUCTION: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. METHODS: The Task Force identified relevant articles using a systematic PubMed search, supplemented with additional published materials, and then created evidence-based recommendations, which were set in categories using criteria adapted from the United States Preventive Services Task Force Agency for Healthcare Research and Quality. The original guidelines provided abundant source material and an excellent organizational structure that served as the basis for the current revised document. RESULTS: The revised guidelines are focused primarily on the diagnosis and treatment of patients with sporadic medullary thyroid carcinoma (MTC) and hereditary MTC. CONCLUSIONS: The Task Force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC. The Task Force considers the recommendations to represent current, rational, and optimal medical practice.
Ähnliche Arbeiten
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 · 16.271 Zit.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 · 6.735 Zit.
Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 · 3.858 Zit.
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 · 3.359 Zit.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2014 · 3.044 Zit.
Autoren
Institutionen
- National Institutes of Health(US)
- National Cancer Institute(US)
- University Health Network(CA)
- University of Toronto(CA)
- Wittenberg University(US)
- University Hospital in Halle(DE)
- Martin Luther University Halle-Wittenberg(DE)
- University of Pisa(IT)
- Medical College of Wisconsin(US)
- The University of Texas MD Anderson Cancer Center(US)
- Memorial Sloan Kettering Cancer Center(US)
- Washington University in St. Louis(US)
- University of Siena(IT)
- Ospedale Santa Maria alle Scotte(IT)
- Heidelberg University(DE)
- University Hospital Heidelberg(DE)
- Heidelberg University(US)
- The University of Sydney(AU)
- University of Kentucky(US)
- Federico II University Hospital(IT)
- Ceinge Biotecnologie Avanzate (Italy)(IT)
- University of Naples Federico II(IT)
- Université Paris-Sud(FR)
- Institut Gustave Roussy(FR)
- The Ohio State University(US)